Vivos Therapeutics announced that its physician‑owned professional practices in Nevada have achieved in‑network status with major commercial insurers and Medicare participation, expanding coverage for its oral appliance treatments for obstructive sleep apnea.
The in‑network status covers UnitedHealthcare, Anthem, Aetna, Cigna, Humana, and other insurers, and is expected to increase patient access and boost management‑services revenue in the Las Vegas market. The company’s acquisition of The Sleep Center of Nevada, announced April 16 2025 and closed June 11 2025, is part of a strategic shift from a dentist‑centric model to a vertically integrated sleep‑care model.
"Being 'in‑network' with these health insurance companies and 'participating' status with Medicare are key milestones for the physician‑owned professional practices we support, with the potential to significantly impact our management services revenue as more patients gain access to our novel OSA treatments. Since our affiliation with Sleep Center of Nevada last June, we have been working diligently to achieve insurance coverage. And while further work remains to be done in this area, as not all supported providers are 'in‑network' with all payers, these developments are highly material to our going forward plan. Equally important, for the first time, the supported practices now have adequate numbers of trained providers to handle the expected increase in demand." – Kirk Huntsman, CEO
The company also disclosed that cost‑reduction initiatives began in February 2026, targeting workforce adjustments and vendor restructuring to save approximately $4 million annually. These savings, combined with the expanded payer acceptance, are intended to lower cash burn and move Vivos toward cash‑flow positivity in fiscal year 2026.
Prior period financials show that Q3 2025 revenue of $6.8 million was a 74% increase over the $3.9 million reported in Q3 2024, and nine‑month revenue of $13.6 million in 2025 exceeded the $11.3 million of the same period in 2024. The new in‑network status is expected to accelerate cash collections and reduce out‑of‑pocket costs for patients who previously faced coverage denials, thereby expanding the company’s addressable market in the greater Las Vegas area.
"Previously, many OSA patients who were excited about Vivos treatment as an alternative to CPAP were denied coverage by their insurance company or Medicare. Some patients paid out of pocket or with third‑party patient financing, but many excellent candidates for OSA treatment were simply unable to proceed due to lack of insurance coverage. The professional practices we support have thousands of previously evaluated patients who can now be contacted regarding the availability of insurance coverage for treatment." – Kirk Huntsman
"Moreover, medical referrals are expected to rise as word spreads that insurance coverage is now available to many more OSA patients seeking Vivos treatment." – Kirk Huntsman
The in‑network status, combined with the company’s strategic pivot and cost‑saving measures, positions Vivos to capture a larger share of the OSA treatment market and move toward sustainable profitability.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.